KM Biologics develops and manufactures human vaccines, antivenom serums, and plasma‑derived therapeutics such as clotting factors, using a vertically integrated biomanufacturing process that ensures high purity and regulatory compliance. It supplies these biologics to hospitals, public health agencies, and clinicians, and offers digital education portals to help patients and healthcare providers with disease prevention, vaccine scheduling, and product usage.
Funding
Funding not disclosed
Founders
Product
Problem
Access to safe and effective vaccines, antivenoms, and plasma‑derived therapeutics can be limited due to complex manufacturing, supply chain constraints, and a lack of localized information for patients and clinicians.
Solution
KM Biologics develops and manufactures human vaccines, antivenom serums, and plasma fractionation products to address unmet therapeutic needs. The company operates a vertically integrated biomanufacturing process that ensures high‑purity, consistent quality, and compliance with regulatory standards. It distributes these biologics to healthcare providers, hospitals, and public health programs, supporting immunization and treatment of toxin‑related diseases. In addition, KM Biologics provides educational resources and digital tools that explain disease prevention, vaccine scheduling, and product usage for patients, families, and medical professionals, helping to improve awareness and adherence.
Target Audience
Primary customers are hospitals, public health agencies, and clinical practitioners requiring vaccines, antivenoms, and plasma‑derived therapeutics, as well as patients and families seeking reliable information on disease prevention and treatment.
Features
- Human vaccine portfolio covering seasonal influenza, hepatitis A, and other indicated diseases
- Antivenom serums targeting venomous bites and envenomation emergencies
- Plasma‑derived fractionated products (e.g., clotting factors) produced with validated purification technologies
- End‑to‑end manufacturing from donor plasma collection to final fill‑finish, ensuring product traceability
- Compliance with international GMP and regulatory guidelines for biologics
- Online patient and clinician portals offering disease education, vaccination schedules, and product information
- Collaboration platform for healthcare institutions to manage inventory and ordering of biologics